Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031

Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031

Summary

ASD is one of the most common developmental disorders worldwide. The condition affects 4% of children worldwide, making the disease exceedingly prevalent. ASD is diagnosed when individuals have difficulty communicating with others, have restricted interests, display repetitive behaviors, and struggle to function in a normal working environment. As symptoms generally manifest in the first two years of life, the condition is regarded as a ‘childhood condition’ however, this report also provides insight into how ASD manifests within the adult population.

GlobalData epidemiologists used age- and sex-specific diagnosed and total prevalence rates and diagnosis rates to forecast the total and diagnosed prevalent cases in each of the 7MM using robust market-specific data. GlobalData epidemiologists applied the country-specific prevalence rates of ASD to each country’s population to obtain the number of estimated diagnosed and total prevalent cases.

The following data describes epidemiology of ASD cases. In 2021, the 7MM had 4,546,591 diagnosed prevalent cases of ASD which is expected to increase to 4,553,323 cases in 2031, at an annual growth rate (AGR) of 0.01%. In the 7MM, the total prevalent cases of ASD will increase from 7,039,947 cases in 2021, to7,054,851 cases in 2031 at an AGR of 0.02%. This increase is partly attributed to the moderately rising trend in historical prevalence in the 7MM, which can be explained by increased awareness of ASD, and decreased stigma surrounding the condition. The underlying demographic change in the respective markets is also responsible for the increase in prevalence. Increased awareness, and early diagnosis of ASD would facilitate improved access to management strategies and improve the daily lives of people living with ASD.

Scope

  • The Autism Spectrum Disorder (ASD) Epidemiology Report provides an overview of the risk factors and global trends of ASD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • This report also includes a 10-year epidemiological forecast for diagnosed and total prevalent cases of ASD segmented by all ages and both sexes. Additionally, diagnosis rates of ASD are included and are segmented into three age groups (children, adolescents, adults).
  • The ASD Epidemiology Report is written and developed by Masters- and PhD-level epidemiologists.
  • The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Reasons to Buy

The Autism Spectrum Disorder Epidemiology series will allow you to -
  • Develop business strategies by understanding the trends shaping and driving the global ASD market.
  • Quantify patient populations in the global ASD market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the demographic with high ASD prevalence that presents the best opportunities ASD therapeutics in each of the markets covered.
  • Understand magnitude of ASD by market prevalence.


1 Autism Spectrum Disorder: Executive Summary
1.1 Catalyst
1.2 Related reports
1.3 Upcoming reports
2 Epidemiology
2.1 Disease background
2.2 Risk factors and comorbidities
2.3 Global and historical trends
2.4 7MM forecast methodology
2.4.1 Sources
2.4.2 Forecast assumptions and methods
2.4.3 Forecast assumptions and methods: total prevalent cases of ASD
2.4.4 Forecast assumptions and methods: diagnosed prevalent cases of ASD - 7MM
2.5 Epidemiological forecast for autism spectrum disorder (2021-31)
2.5.1 Total prevalent cases of ASD
2.5.2 Age-specific total prevalent cases of ASD
2.5.3 Sex-specific total prevalent cases of ASD
2.5.4 Diagnosed prevalent cases of ASD
2.5.5 Age-specific diagnosed prevalent cases of ASD
2.5.6 Sex-specific diagnosed prevalent cases of CKD
2.6 Discussion
2.6.1 Epidemiological forecast insight
2.6.2 COVID-19 impact
2.6.3 Limitations of the analysis
2.6.4 Strengths of the Analysis
3 Appendix
3.1 Bibliography
3.2 Primary research - prescriber survey
3.3 About the authors
3.3.1 Epidemiologist
3.3.2 Reviewers
3.3.3 Global Director of Therapy Analysis and Epidemiology
3.3.4 Global Head and EVP of Healthcare Operations and Strategy
Contact Us
List of Tables
Table 1. Summary of newly added data types
Table 2: Summary of updated data types
Table 3: Risk factors and comorbidities for ASD
Table 4: High-prescribing physicians (non-KOLs) surveyed, by country
List of Figures
Figure 1: 7MM, total prevalent cases of autism spectrum disorder (ASD), both sexes, N, all ages, 2021 and 2031
Figure 2: 7MM, diagnosed prevalent cases of autism spectrum disorder (ASD), both sexes, N, All Ages, 2021 and 2031
Figure 3: 7MM, diagnosed prevalence of autism spectrum disorder (ASD), both sexes, %, all ages, 2021
Figure 4: 7MM, sources used and not used to forecast the total prevalent cases of ASD
Figure 5: 7MM, sources used and not used to forecast the diagnosed prevalent cases of ASD
Figure 6: 7MM, total prevalent cases of ASD, N, men and women, all ages, 2021
Figure 7: 7MM age-specific total prevalent cases of ASD, N, men and women, 2021
Figure 8: 7MM total prevalent cases of ASD by sex, N, all ages, 2021
Figure 9: 7MM diagnosed prevalent cases of ASD, N, men and women, all ages, 2021
Figure 10: 7MM age-specific diagnosed prevalent cases of ASD, N, men and women, all ages, 2021
Figure 11: 7MM diagnosed prevalent cases of ASD by sex, N, all ages, 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings